VTVT vTv Therapeutics Inc. Net earnings per share for the last 12 months

Public company logo of vtvtherapeutics.com (VTVT)

The 12-month net income per share snapshot on this GURU.Markets chart shows that the current level is around -0.91. vTv Therapeutics Inc. (VTVT) aims for leadership in type 1 diabetes treatment through glucokinase activation with cadisegliat. The business model relies on the success of TTP399 and global partnerships; however, pricing power will only emerge following drug approval during final testing.

VTVT (vTv Therapeutics Inc) Net earnings per share (EPS TTM) history from 07/04/2022 to 11/18/2026

Analytical breakdowns and data insights for company vTv Therapeutics Inc. (VTVT)

- stock price and consensus target price:
Fundamental company valuation:vTv Therapeutics Inc. (VTVT)
Mass-produced product of vTv Therapeutics Inc

The use of AI in molecular screening and the automation of drug synthesis optimize costs for vTv Therapeutics Inc. (VTVT). Analyzing this 12-month net income per share chart allows an investor to see the real efficiency of the business. This metric divides total net income by the total number of shares, excluding the impact of issuances. This enables an assessment of the fundamental return on each ownership stake. The trend of this indicator determines the objective value of the asset independent of market speculation.

Competitors of vTv Therapeutics Inc.

Ascendis - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Madrigal Pharma|CORT (Corcept Therapeutics Incorporated) - Net earnings per share for the last 12 months|RYTM: Earnings per share for the last four quarters|AKRO (Akero Corp) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) Metsera Inc|Net earnings per share (EPS TTM) MLTX|Earnings per share for the last twelve months CRNX (Crinetics Pharmaceuticals, Inc.)|Earnings per share for the last twelve months newamsterdampharma.com NAMS|Soleno Therapeutics Corp (SLNO) - Net earnings per one share for the last twelve months|FOLD - Earnings per share for the last twelve months|ETNB: Earnings per share for the last twelve months|AGIO: Net earnings per share (EPS TTM)|GPCR - Net earnings per share for the last four quarters|Earnings per share for the last twelve months MiMedx Corp|Rezolute Bio (RZLT) - Net earnings per share for the last four quarters|Earnings per share for the last twelve months lexpharma.com (LXRX)|Net earnings per share for the last 12 months MBX Biosciences Inc MBX|Earnings per share for the last twelve months Altimmune ALT|Net earnings per share (EPS TTM) Aardvark Therapeutics AARD|Sagimet Biosciences, Inc. - Net earnings per share (EPS TTM)|Net earnings per share for the last four quarters BioAge Labs, Inc BIOA|Biomea Fusion Inc (BMEA) - Earnings per share for the last twelve months|QNCX - Net earnings per share for the last four quarters|GUTS (Fractyl Health Inc.) - Net earnings per share (EPS TTM)|Agape ATP Corporation - Earnings per one share for the last 12 months|Net earnings per share (EPS TTM) PLUR|SYBX - Net earnings per one share for the last twelve months|Net earnings per share (EPS TTM) LPCN (lipocine.com)|Net earnings per share (EPS TTM) Matinas BioPharma MTNB|SPRB: Net earnings per share for the last 12 months|Net earnings per one share for the last twelve months Galecto Corp|CTCX (Carmell Corp) - Net earnings per share for the last 12 months|Lumos Pharma Corp - Earnings per share for the trailing year|Net earnings per share for the last 12 months ONVO|Net earnings per one share for the last twelve months Radius Recycling, Inc. RDUS